Home / Uncategorized / FDA’s Avastin decision sends breast cancer patients reeling

FDA’s Avastin decision sends breast cancer patients reeling

Agency pulls blockbuster drug’s approval for breast cancer, saying evidence doesn’t confirm benefit

View post:
FDA’s Avastin decision sends breast cancer patients reeling

If you enjoyed this post, make sure you subscribe to my RSS feed!

About Philippe Matthews

Scroll To Top